Muscle abnormalities worsen after post-exertional malaise in long COVID

[1]  M. Landthaler,et al.  Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles , 2023, Acta Neuropathologica Communications.

[2]  L. Brocca,et al.  Structural and functional impairments of skeletal muscle in patients with post-acute sequelae of SARS-CoV-2 infection. , 2023, Journal of applied physiology.

[3]  T. van der Poll,et al.  Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection , 2023, EBioMedicine.

[4]  D. Buonsenso,et al.  Lung perfusion assessment in children with long‐COVID: A pilot study , 2023, Pediatric pulmonology.

[5]  A. Woodcock,et al.  Long COVID: pathophysiological factors and abnormalities of coagulation , 2023, Trends in Endocrinology & Metabolism.

[6]  K. Stronks,et al.  Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study , 2023, The Lancet Regional Health - Europe.

[7]  E. Bernasconi,et al.  Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course , 2023, Nature Immunology.

[8]  H. Bøtker,et al.  Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology , 2023, Clinical Neurophysiology.

[9]  E. Topol,et al.  Long COVID: major findings, mechanisms and recommendations , 2023, Nature Reviews Microbiology.

[10]  M. van Vugt,et al.  Post COVID‐19 condition: critical need for a clear definition and detailed pathophysiology , 2022, Journal of cachexia, sarcopenia and muscle.

[11]  D. Kell,et al.  Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system , 2022, Cardiovascular Diabetology.

[12]  T. Radtke,et al.  Low Cardiorespiratory Fitness Post-COVID-19: A Narrative Review , 2022, Sports Medicine.

[13]  J. Rittweger,et al.  Capillary rarefaction during bed rest is proportionally less than fibre atrophy and loss of oxidative capacity , 2022, Journal of cachexia, sarcopenia and muscle.

[14]  C. D. Dela Cruz,et al.  Distinguishing features of long COVID identified through immune profiling , 2022, Nature.

[15]  G. Gkoutos,et al.  Symptoms and risk factors for long COVID in non-hospitalized adults , 2022, Nature Medicine.

[16]  A. Borczuk,et al.  SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery , 2022, Science Translational Medicine.

[17]  H. Tankisi,et al.  Myopathy as a cause of fatigue in long‐term post‐COVID‐19 symptoms: Evidence of skeletal muscle histopathology , 2022, European journal of neurology.

[18]  Z. Al-Aly,et al.  Long COVID after breakthrough SARS-CoV-2 infection , 2022, Nature Medicine.

[19]  B. Palmer,et al.  SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2 , 2022, PLoS pathogens.

[20]  R. Houtkooper,et al.  Polar metabolomics in human muscle biopsies using a liquid-liquid extraction and full-scan LC-MS , 2022, STAR protocols.

[21]  X. Mao,et al.  Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome , 2022, JCI insight.

[22]  P. Bridevaux,et al.  Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in ‘long COVID’ patients with persistent dyspnoea , 2022, BMJ Open Respiratory Research.

[23]  S. Benkovic,et al.  The Purinosome: A Case Study for a Mammalian Metabolon. , 2022, Annual review of biochemistry.

[24]  R. Mezzenga,et al.  Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19 , 2022, Nature Communications.

[25]  A. Murray,et al.  Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19 , 2022, Journal of cachexia, sarcopenia and muscle.

[26]  L. Abid,et al.  Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study , 2021, Frontiers in Cardiovascular Medicine.

[27]  B. Paiva,et al.  Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome , 2021, Frontiers in Immunology.

[28]  A. Fontanet,et al.  Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection , 2021, EBioMedicine.

[29]  P. Heerdt,et al.  Persistent Exertional Intolerance After COVID-19 , 2021, Chest.

[30]  K. Stavem,et al.  Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation , 2021, European Respiratory Journal.

[31]  T. Triche,et al.  Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection , 2021, bioRxiv.

[32]  Sara E. Miller,et al.  Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells , 2021, bioRxiv.

[33]  C. Rice,et al.  Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection , 2021, Nature.

[34]  F. Heppner,et al.  Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. , 2021, JAMA neurology.

[35]  D. Kell,et al.  Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin , 2021, Cardiovascular Diabetology.

[36]  B. Ekblom,et al.  Variablity in vastus lateralis fiber type distribution, fiber size and myonuclear content along and the between legs. , 2021, Journal of applied physiology.

[37]  R. Sanders,et al.  Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination , 2021, EBioMedicine.

[38]  B. Brundel,et al.  The Antibiotic Doxycycline Impairs Cardiac Mitochondrial and Contractile Function , 2021, International journal of molecular sciences.

[39]  Elizabeth B White,et al.  Diverse Functional Autoantibodies in Patients with COVID-19 , 2020, Nature.

[40]  S. Zurac,et al.  Histological findings in skeletal muscle of SARS-CoV2 infected patient , 2020, Journal of immunoassay & immunochemistry.

[41]  Daniel Arvidsson,et al.  Effect of sampling rate on acceleration and counts of hip- and wrist-worn ActiGraph accelerometers in children , 2019, Physiological measurement.

[42]  D. P. Lewis,et al.  An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients , 2019, International journal of molecular sciences.

[43]  D. P. Lewis,et al.  Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases , 2019, Diagnostics.

[44]  L. Jason,et al.  A Brief Questionnaire to Assess Post-Exertional Malaise , 2018, Diagnostics.

[45]  S. Grazioli,et al.  Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases , 2018, Front. Immunol..

[46]  K. Nakahira,et al.  The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases. , 2015, Antioxidants & redox signaling.

[47]  B. Saltin,et al.  Mitochondrial coupling and capacity of oxidative phosphorylation in skeletal muscle of Inuit and Caucasians in the arctic winter , 2015, Scandinavian journal of medicine & science in sports.

[48]  H. ten Cate,et al.  Short- and Long-term exercise induced alterations in haemostasis: a review of the literature. , 2015, Blood reviews.

[49]  Birk Diedenhofen,et al.  cocor: A Comprehensive Solution for the Statistical Comparison of Correlations , 2015, PloS one.

[50]  V. Teplova,et al.  Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophils , 2012, Journal of Biomedical Science.

[51]  E. Gnaiger.  Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. , 2009, The international journal of biochemistry & cell biology.

[52]  M. Hopman,et al.  Region-specific adaptations in determinants of rat skeletal muscle oxygenation to chronic hypoxia. , 2009, American journal of physiology. Heart and circulatory physiology.

[53]  Lauren B. Krupp,et al.  Fatigue in multiple sclerosis. , 1988, Archives of neurology.

[54]  L. Hedges.  Distribution Theory for Glass's Estimator of Effect size and Related Estimators , 1981 .

[55]  David R. Walt,et al.  Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae , 2022 .